Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “De Novo Renal Transplant Recipient.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00251004
What this trial is testing

Efficacy and Safety Study of Everolimus Plus Reduced Cyclosporine Versus Mycophenolic Acid Plus Cyclosporine in Kidney Transplant Recipients

Who this might be right for
Kidney TransplantationGraft Rejection
Novartis 833
Not applicableWithdrawnNCT01612299
What this trial is testing

Effects of Zortress® + Tacrolimus vs. Standard Immunosuppression on Progression of Coronary Artery Calcifications and Bone Disease in de Novo Renal Transplant Recipients

Who this might be right for
Renal Transplant
University of Kentucky
Post-approval studies (Phase 4)UnknownNCT04700709
What this trial is testing

Efficacy and Safety of Sirolimus Plus CNI Compared With MMF Plus CNI in ABO-i Kidney Transplant Recipients.

Who this might be right for
Kidney Transplantation
Chong Kun Dang Pharmaceutical 158
Testing effectiveness (Phase 2)Study completedNCT00543569
What this trial is testing

Assess the Safety and Efficacy of Alefacept in Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
Astellas Pharma Inc 323
Testing effectiveness (Phase 2)Study completedNCT01666951
What this trial is testing

Multicenter, Prospective, Rand, PK Study of LCP-Tacro™ Compared to Prograf® Capsules in De Novo Adult Kidney Transplant

Who this might be right for
Renal Failure
Veloxis Pharmaceuticals 36
Large-scale testing (Phase 3)Study completedNCT00150046
What this trial is testing

Efficacy and Safety of Everolimus in de Novo Heart Transplant Recipients

Who this might be right for
Heart Transplantation
Novartis Pharmaceuticals 176
Testing effectiveness (Phase 2)Study completedNCT05669001
What this trial is testing

TCD601 in de Novo Renal Transplant Recipients

Who this might be right for
Renal Transplantation
ITB-Med LLC 76
Post-approval studies (Phase 4)Study completedNCT00195429
What this trial is testing

A Study Comparing the Withdrawal of Steroids or Tacrolimus in Kidney Transplant Recipients

Who this might be right for
Kidney FailureGraft vs Host Disease
Wyeth is now a wholly owned subsidiary of Pfizer 47
Testing effectiveness (Phase 2)Study completedNCT00239798
What this trial is testing

Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 255
Post-approval studies (Phase 4)Study completedNCT00154245
What this trial is testing

A One-year, Open Label Study to Investigate the Safety and the Effect of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion in de Novo Kidney Transplant Recipients.

Who this might be right for
Kidney Transplantation
Novartis 20
Large-scale testing (Phase 3)Study completedNCT00378014
What this trial is testing

Preservation of Renal Function in Liver Transplant Recipients With Certican Therapy

Who this might be right for
Liver Transplantation
Novartis Pharmaceuticals 276
Large-scale testing (Phase 3)Study completedNCT01625377
What this trial is testing

A National Multi-center Randomized, Open Label Study to Evaluate Efficacy and Safety of Everolimus With EC-MPS Compared to Standard Treatment Combination Tacrolimus and EC-MPS in de Novo Liver Transplant Recipients

Who this might be right for
Liver Transplantation
Novartis Pharmaceuticals 188
Post-approval studies (Phase 4)Study completedNCT00275522
What this trial is testing

The Comparison of Three Different Immunosuppressant Regimens in Kidney Transplant Recipients.

Who this might be right for
Kidney Transplant
Mayo Clinic 16
Early research (Phase 1)Active Not RecruitingNCT03726307
What this trial is testing

Allogeneic Regulatory Dendritic Cell (DCreg) Renal Study

Who this might be right for
Kidney TransplantRenal Transplant Recipients
Angus W. Thomson PhD DSc 28
Testing effectiveness (Phase 2)Ended earlyNCT00282230
What this trial is testing

Evaluate the Safety and Efficacy of Prograf/FK778 and Prograf/MMF in de Novo Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
Astellas Pharma Inc 150
Post-approval studies (Phase 4)Study completedNCT01183247
What this trial is testing

An Open, Single Centre, Randomised, Parallel Group Study to Investigate Three Different Immunosuppressive Regimens

Who this might be right for
Comparative StudyImmunosuppressive Agents
University Hospital, Basel, Switzerland 63
Large-scale testing (Phase 3)Study completedNCT02040584
What this trial is testing

A Multicentre, Randomised, Open-label, Controlled, 12-month Follow-up Study to Assess Impact on Renal Function of an Immunosuppression Regimen Based on Tacrolimus Minimisation in Association With Everolimus in de Novo Liver Transplant Recipients.

Who this might be right for
Liver Transplant
Novartis Pharmaceuticals 217
Post-approval studies (Phase 4)Study completedNCT00634920
What this trial is testing

Evaluation of Early Conversion to Everolimus From Cyclosporine in de Novo Renal Transplant Recipients

Who this might be right for
Renal Function
Novartis Pharmaceuticals 204
Large-scale testing (Phase 3)Ended earlyNCT00137345
What this trial is testing

Study Comparing Sirolimus With Cyclosporine in a Calcineurin Inhibitor (CNI)-Free Regimen in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant
Wyeth is now a wholly owned subsidiary of Pfizer 500
Testing effectiveness (Phase 2)Study completedNCT00307125
What this trial is testing

Rituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA Alloantibodies

Who this might be right for
Kidney TransplantKidney Transplant RecipientGraft Function/Survival+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 757
Next Page